Theseus Pharmaceuticals Inc
NASDAQ:THRX
Theseus Pharmaceuticals Inc
Other Current Liabilities
Theseus Pharmaceuticals Inc
Other Current Liabilities Peer Comparison
Competitive Other Current Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Other Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Theseus Pharmaceuticals Inc
NASDAQ:THRX
|
Other Current Liabilities
$300k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Johnson & Johnson
NYSE:JNJ
|
Other Current Liabilities
$3.3B
|
CAGR 3-Years
21%
|
CAGR 5-Years
17%
|
CAGR 10-Years
14%
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Other Current Liabilities
$6.2B
|
CAGR 3-Years
15%
|
CAGR 5-Years
32%
|
CAGR 10-Years
13%
|
|
Pfizer Inc
NYSE:PFE
|
Other Current Liabilities
$24.5B
|
CAGR 3-Years
15%
|
CAGR 5-Years
12%
|
CAGR 10-Years
8%
|
|
Merck & Co Inc
NYSE:MRK
|
Other Current Liabilities
$5.4B
|
CAGR 3-Years
19%
|
CAGR 5-Years
17%
|
CAGR 10-Years
7%
|
|
Eli Lilly and Co
NYSE:LLY
|
Other Current Liabilities
$4.2B
|
CAGR 3-Years
5%
|
CAGR 5-Years
9%
|
CAGR 10-Years
3%
|
See Also
What is Theseus Pharmaceuticals Inc's Other Current Liabilities?
Other Current Liabilities
300k
USD
Based on the financial report for Dec 31, 2022, Theseus Pharmaceuticals Inc's Other Current Liabilities amounts to 300k USD.
What is Theseus Pharmaceuticals Inc's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 1Y
-50%
Over the last year, the Other Current Liabilities growth was -50%.